Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2b Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)

NCT03274206 is registered in ClinicalTrials.gov with BioLeaders Corporation as lead sponsor.

NCT NCT03274206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03274206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2b Trial to Evaluate the Efficacy and Safety of BLS-ILB-E710c in Patients With Cervical Intraepithelial Neoplasia 2/3 (CIN2/3)
Lead sponsor
BioLeaders Corporation
Phase
Phase 2
Overall status
Unknown status
Start date
August 30, 2017
Completion date
August 31, 2020
Enrollment
126 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia grade 2/3